Esther Mendez

Dr. Esther Mendez

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Minerva Anestesiologica
Verified
Journal Article
Closed access
EMEsther Mendez
Esther Mendez
GPGuillermo Puig
Guillermo Puig
MBMarta Barquero
Marta Barquero
ALAriadna Leon
Ariadna Leon
JBJavier Bellafont
Javier Bellafont
MCMaria J. Colomina
Maria J. Colomina
Article: Enhanced recovery after surgery: a narrative review on patient blood management recommendations - Minerva Anestesiologica 2023 Jun 12 - Minerva Medica - Journals

6 May 2025 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
SPSalvador Payán-Pernía
Salvador Payán-Pernía
EMEsther Mendez
Esther Mendez
JBJosé Luis Pérez Blanco
José Luis Pérez Blanco
MNMiguel Ángel Navarro-García
Miguel Ángel Navarro-García
JMJuan B Martínez-León
Juan B Martínez-León
JGJosé Antonio García-Erce
José Antonio García-Erce

1 June 2026 in Minerva Anestesiologica
Verified
Journal Article
Closed access
EMEsther Mendez
Esther Mendez
JVJorge Vallés
Jorge Vallés
ÁCÁngel Candela
Ángel Candela
GPGuillermo Puig
Guillermo Puig
MBMisericòrdia Basora
Misericòrdia Basora
MCMaria J. Colomina
Maria J. Colomina
Transfusion practices in cardiac valve surgery remain variable despite evidence supporting integrated patient blood management strategies. This study evaluated the independent and combined effects of preoperative hemoglobin status and intraoperative blood conservation techniques on transfusion requirements in elective open cardiac valve surgery. We conducted a nationwide retrospective multicenter cohort study using data from the national Maturity Assessment Model for Patient Blood Management registry. Adult patients undergoing elective open cardiac valve surgery between 2016 and 2022 in 23 Spanish hospitals were included. Anemia was defined as preoperative hemoglobin <13 g/dL, irrespective of sex. The primary outcome was red blood cell transfusion during the index hospital admission. A total of 9889 patients were analyzed, with an overall transfusion rate of 53%. Anemic patients (37.3%) had higher transfusion rates than non-anemic patients (70.2% vs. 42.7%). In a separate model restricted to 5763 patients with intraoperative data, combined use of tranexamic acid and intraoperative cell salvage was associated with lower transfusion risk compared with no blood conservation strategy (47.7% vs. 52.3%; adjusted odds ratio 0.83; 95% confidence interval 0.71-0.97), whereas use of either strategy alone showed no meaningful transfusion reduction. When preoperative hemoglobin status and intraoperative strategies were analyzed jointly, the lowest transfusion rate (37.6%) occurred in non-anemic patients receiving both strategies, whereas anemic patients without blood conservation had the highest rate (74.9%; adjusted odds ratio 4.95; 95% confidence interval 4.10-5.97). Combined implementation of adequate preoperative hemoglobin levels and intraoperative blood conservation strategies was associated with lower transfusion rates in elective cardiac valve surgery, supporting the value of integrated perioperative patient blood management pathways in real-world practice.

1 January 2010 in Revista Española de Anestesiología y Reanimación
Verified
Journal Article
Closed access
EMEsther Mendez
Esther Mendez
EME. Moret
E. Moret
CLC. Llubià
C. Llubià
JSJ. Sanz
J. Sanz
PCP.E. López de Castro
P.E. López de Castro
XRX. Ruyra
X. Ruyra

5 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EMEsther Mendez
Esther Mendez
Elvira BisbeElvira Bisbe
Elvira Bisbe
MBMisericordia Basora
Misericordia Basora
AVAdrian Vizoso
Adrian Vizoso
AGAlbert García-Casanovas
Albert García-Casanovas
MCMaria J. Colomina
Maria J. Colomina
Background/Objectives: Sex-specific anemia criteria classify women with hemoglobin (Hb) 12.0–12.9 g/dL as non-anemic. We assessed whether World Health Organization (WHO) criteria underrecognize red blood cell (RBC) transfusion risk compared with a uniform patient blood management (PBM) threshold of Hb <13.0 g/dL in elective open cardiac valve surgery (CVS). Methods: This nationwide retrospective cohort included adults undergoing elective open CVS in 40 Spanish centers (2016–2024), 32 of which reported preoperative Hb. Hb was modeled continuously and in three strata (<12.0, 12.0–12.9, ≥13.0 g/dL). The primary outcome was RBC transfusion; secondary outcomes were postoperative complications, length of stay, and in-hospital mortality within 30 days. Mixed-effects models adjusted for age, comorbidity burden, surgical complexity, valve position, year of surgery, and center. Results: Among 29,757 eligible patients, 20,017 had available Hb measurements; 9247 (46.2%) were women, including 2333 (25.2%) with Hb 12.0–12.9 g/dL. In this stratum, 68.0% of women and 52.7% of men received RBC transfusions. The adjusted between-sex probability difference was 15.1 percentage points (95% CI, 11.4–18.9; adjusted odds ratio, 1.85; 95% CI, 1.59–2.16). The categorical sex × Hb interaction was significant (p < 0.001), whereas the continuous interaction was not (p = 0.486). Sex did not significantly modify the Hb associations with complications or in-hospital mortality within 30 days. Conclusions: Women with Hb 12.0–12.9 g/dL had substantial transfusion risk despite being classified as non-anemic by the WHO criteria. Hb <13.0 g/dL may be a pragmatic sex-inclusive trigger for perioperative risk recognition and etiologic evaluation, not a proven therapeutic target.

1 January 2022 in Revista Española de Anestesiología y Reanimación
Verified
Journal Article
Closed access
EMEsther Mendez
Esther Mendez
AAA. Serrano Afonso
A. Serrano Afonso